pharmaceuticals

White House Drafts Drug Pricing Legislation, Shares with Pharma Companies

by

Trump Administration Pushes for Legislative Drug Pricing Reform Washington D.C. – The White House is actively working to translate its voluntary drug pricing agreements with pharmaceutical companies into formal legislation. Officials are currently sharing draft legislative text with over a dozen major pharmaceutical companies, signaling a continued commitment to lowering prescription drug costs. Building on … Read more

INO DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action

by

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to seize a leadership … Read more

AstraZeneca stock jumps after surprise lung disease trial win

by

AstraZeneca’s COPD Breakthrough: A New Dawn for Lung Disease Treatment? AstraZeneca’s stock surged nearly 5% today following the announcement of positive Phase III trial results for tozorakimab, a novel treatment for Chronic Obstructive Pulmonary Disease (COPD). The drug significantly reduced flare-ups in both former and current smokers, marking a potential turning point in the fight … Read more

Drug Kickbacks: Pharma Paid Just 2.2% of Sales in Penalties

by

Pharmaceutical Kickbacks: A Quarter-Century of Penalties and What’s Next For decades, the pharmaceutical industry has faced scrutiny over practices designed to influence prescribing habits. A recent analysis reveals that, between 2000 and 2025, 64 cases resulted in settlements with the U.S. Government due to alleged kickbacks to physicians. These kickbacks aimed to boost medicine sales … Read more

CVS Health Faces Test in Tennessee Over PBM Ownership

by

Tennessee Bill Sparks National Debate Over Pharmacy Benefit Managers A bill currently moving through the Tennessee legislature is igniting a national conversation about the role of pharmacy benefit managers (PBMs) and the future of the pharmaceutical industry. The proposed legislation, Senate Bill 2040, could dramatically reshape how prescription drugs are managed in the state and … Read more

Conduit Pharmaceuticals Faces Critical Juncture After Pivot to Biotech

by

Biotech Pivot, Nasdaq Compliance March 23, 2026 Conduit Pharmaceuticals’ ambitious shift from real estate to biotech is facing headwinds, with a low market cap and Nasdaq listing concerns prompting a reverse stock split. Conduit Pharmaceuticals Faces Critical Juncture After Pivot to Biotech The transformation from a special purpose acquisition company (SPAC) focused on real estate … Read more

INO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to take a leading … Read more

Middle East Conflict: Impact on Global Pharmaceutical Supply Chains

by

Iran Conflict: A Looming Shadow Over Pharmaceutical Supply Chains The recent escalation of conflict in the Middle East hasn’t yet caused widespread disruption to global pharmaceutical supplies, but experts warn that the potential for significant impact is growing. While current production in the immediate conflict zone represents a minor fraction of global output – just … Read more

How CNBC Cures is bringing rare disease stories to a national audience

by

CNBC Cures: A Turning Tide for Rare Disease Awareness and Innovation The launch of CNBC Cures, spearheaded by Becky Quick and her sister, marks a significant shift in how rare diseases are discussed and addressed. What began as a personal mission – driven by Quick’s own family’s experience with a rare disease diagnosis – has … Read more

Ozempic is getting generics as low as $15 — what it means for Americans

by

India’s Ozempic Revolution: Will Cheaper Weight Loss Drugs Reach US Shores? The global weight-loss landscape is on the cusp of a dramatic shift. This weekend marks a pivotal moment as Indian pharmaceutical companies gain the green light to manufacture and sell generic versions of Ozempic and Wegovy, the blockbuster drugs transforming diabetes and obesity treatment. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com